Table 3.

Odds Ratio [95% CI] for predictors of medication use over time.

	Aspirin	Statin	ACEI/ARB	Beta-blocker	“Global” medication adherence
3 months vs baseline	1.18 [0.89, 1.55]	1.58‡ [1.16, 2.16]	1.33 [0.98, 1.80]	1.60 [0.96, 2.66]	1.26 [0.96, 1.65]
6 months vs baseline	1.70‡ [1.23, 2.36]	1.74‡ [1.18, 2.56]	1.17 [0.86, 1.60]	1.39 [0.82, 2.33]	1.15 [0.87, 1.51]
12 months vs baseline	1.90‡ [1.24, 2.91]	1.32 [0.83, 2.09]	1.18 [0.82, 1.70]	0.96 [0.49, 1.86]	1.17 [0.84, 1.62]
GAP vs control	11.18‡ [4.63, 27.03]	1.35 [0.62, 2.94]	1.92⁎ [1.03, 3.63]	0.16⁎ [0.04, 0.66]	2.34‡ [1.28, 4.30]
(Age + 1) vs age	1.00 [0.95, 1.05]	1.05⁎ [1.00, 1.10]	1.01 [0.97,1.04]	1.12‡ [1.04, 1.21]	1.00 [0.98, 1.03]
Female vs male	0.93 [0.45, 1.95]	2.29⁎ [1.03, 5.08]	0.64 [0.33, 1.21]	0.48 [0.14, 1.58]	0.74 [0.40, 1.35]
Asian vs White	1.43 [0.45, 4.54]	1.15 [0.28, 4.66]	0.61 [0.23, 1.57]	0.38 [0.06, 2.36]	0.53 [0.21, 1.30]
Black vs White	1.19 [0.49, 2.92]	3.04‡ [1.37, 6.73]	1.07 [0.55, 2.08]	3.85 [0.81, 18.35]	1.04 [0.55, 1.97]
Other vs White	0.63 [0.19, 2.12]	2.17 [0.44, 10.76]	2.33 [0.53, 10.24]	3.48 [0.57, 21.41]	2.02 [0.56, 7.28]
CAD vs no CAD	3.07 [0.98, 9.65]	1.83 [0.63, 5.31]	0.78 [0.33, 1.84]	11.06‡ [2.50, 48.74]	0.63 [0.28, 1.45]
No IHP vs IHP	2.17 [0.66, 7.06]	1.06 [0.40, 2.79]	1.30 [0.62, 2.73]	5.51⁎ [1.34, 22.61]	1.27 [0.63, 2.56]
No Medicare vs Medicare	0.88 [0.31, 2.46]	1.42 [0.54, 3.66]	0.88 [0.41, 1.89]	1.26 [0.28, 5.73]	0.83 [0.40, 1.74]
No Medicaid vs Medicaid	2.33 [0.88, 6.18]	1.19 [0.48, 2.91]	1.18 [0.57, 2.39]	1.35 [0.43, 4.30]	1.30 [0.66, 2.56]
HTN vs no HTN	4.08‡ [1.53, 10.87]	1.58 [0.64, 3.89]	7.38‡ [3.65, 14.93]	4.99‡ [1.51, 16.49]	5.62‡ [2.82, 11.19]

ACEI: angiotensin converting enzyme inhibitor.

ARB: angiotensin receptor blocker.

IHP: Ingham Health Plan insurance.

CAD: coronary artery disease.

HTN: hypertension.

GAP: Guidelines Applied to Practice.

Adjusted for hypertension, diabetes mellitus, and variables in the propensity score.

^‡p-Value < 0.01.

^⁎p-Value < 0.05.